Skip to main content
Caplight Logo









i&i Prague

i&i Prague

Overview

i&i Prague is a Prague-based biotech incubator and venture builder that scouts, supports, and provides pre-seed or seed financing to promising projects from academic institutions in the fields of Drug Discovery, Diagnostics, and MedTech.

Year Founded

2017

Portfolio Companies

17

Investments

i&i Prague investments
CompanyDateStageLead
CasInvent PharmaMay 2024SeedCo-investor
Dracen Pharmaceuticals, Inc.Mar 2022Series A ExtensionCo-investor
HeartBeat.bio AGNov 2023VC RoundLead
Elphogene, s.r.o.-SeedLead
Delta Life ScienceMay 2023Series ACo-investor
Book a demo to see all 17 portfolio companies

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is i&i Prague based?

i&i Prague is headquartered in Prague, Czech Republic.

When was i&i Prague founded?

i&i Prague was founded in 2017.

How many portfolio companies does i&i Prague have?

i&i Prague has 17 portfolio companies in Caplight's dataset.

What are some companies in i&i Prague's portfolio?

Portfolio companies visible on Caplight include CasInvent Pharma, Dracen Pharmaceuticals, Inc., HeartBeat.bio AG, Elphogene, s.r.o., Delta Life Science.

What was i&i Prague's most recent investment shown here?

i&i Prague's most recent investment in this portfolio sample was in CasInvent Pharma in 2024.

What sectors does i&i Prague focus on?

i&i Prague focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, Consumer & Commerce, AI, Data & Cloud Infrastructure.

What company stages does i&i Prague focus on?

i&i Prague typically invests at the Early stage.

What is i&i Prague's AUM?

i&i Prague's assets under management are estimated between $56.7M and $56.7M.

Firmographic Details

HeadquartersPrague
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?